One Hundred Fourteenth Congress of the United States of America
Begun and held at the City of Washington on Monday, the fourth day of January, two thousand and sixteen
IN THE SENATE OF THE UNITED STATES
To expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.
This Act may be cited as the
Adding Zika Virus to the FDA Priority Review Voucher Program Act.
Expanding tropical disease product priority review voucher program to encourage treatments for Zika Virus Disease
Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended—
by redesignating subparagraph (R) as subparagraph (S);
in subparagraph (Q), by striking
Filoviruses and inserting
Filovirus Diseases; and
by inserting after subparagraph (Q) the following:
Zika Virus Disease.
Speaker of the House of Representatives
Vice President of the United States and President of the Senate